Project Details
Description
Harnessing the glucose lowering actions of alpha-melanocyte stimulatory hormone as a potential new therapy for people with type 1 diabetes mellitus.
| Status | Finished |
|---|---|
| Effective start/end date | 1/07/23 → 13/09/25 |
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.